NURSING JURISPRUDENCE AND ETHICS FOR TEXAS NURSES PRACTICE TEST 2026 TESTED QUESTIONS WITH VERIFIED ANSWERS GRADED A+

NURSING JURISPRUDENCE AND ETHICS
FOR TEXAS NURSES ACTUAL EXAM PAPER
2026 QUESTIONS WITH ANSWERS GRADED
A+

⩥ According to Massachusetts Pharmacy Law, a written prescription for
a controlled substance in Schedule II shall become invalid SIX months
after the date of issuance.


A) True


B) False. Answer: (b) False, [Massachusetts Controlled Substance Act
Chapter 94C: Section 23(a)].


According to Massachusetts Pharmacy Law, a written prescription for a
controlled substance in Schedule II shall become invalid THIRTY
DAYS (30) after the date of issuance.


A written prescription for a controlled substance in Schedule II shall not
be refilled and shall be kept in a separate file.


The pharmacist filling a written prescription for a controlled substance
in Schedule II shall endorse his own signature on the face thereof.

,⩥ Which of the following information IS/ARE TRUE about voluntary
non-opiate directive form?


I. The form shall indicate to all practitioners that an individual shall not
be administered or offered a prescription or medication order for an
opiate.


II. An individual may execute and file a voluntary non-opiate directive
form with a registered practitioner or other authority authorized by the
secretary to accept the voluntary non-opiate directive form for filing.


III. An individual may revoke the voluntary non-opiate directive form
for any reason and may do so by written or oral means.


A) I only


B) I and II only


C) II and III only


D) All of the above. Answer: (d) All, [Massachusetts Controlled
Substance Act Chapter 94C: Section 18B].

,(a). The department shall establish a voluntary non-opiate directive
form. The form shall indicate to all practitioners that an individual shall
not be administered or offered a prescription or medication order for an
opiate.


The form shall be posted on the department's searchable website. An
individual may execute and file a voluntary non-opiate directive form
with a registered practitioner or other authority authorized by the
secretary to accept the voluntary non-opiate directive form for filing.


An individual may revoke the voluntary non-opiate directive form for
any reason and may do so by written or oral means.


A written prescription that is presented at an outpatient pharmacy or a
prescription that is electronically transmitted to an outpatient pharmacy
shall be presumed to be valid for the purposes of this section and a
pharmacist in an outpatient setting shall not be held in violation of this
section for dispensing a controlled substance in contradiction to a
voluntary non-opiate directive form, except upon evidence that the
pharmacist acted knowingly against the voluntary non-opiate directive
form.


Any board of professional licensure may limit, condition or suspend the
license of or assess fines against a licensed health care provider who
recklessly or negligently fails to comply with a person's voluntary non-
opiate directive form.

, ⩥ In order for a pharmacist to enter into a collaborative practice
agreement, the pharmacist shall:


I. hold a current license to practice pharmacy in the commonwealth and
currently be engaged in pharmacy practice in the commonwealth.


II. have earned a doctor of pharmacy degree or have completed 5 years
of experience as a licensed pharmacist or the equivalent.


III. have at least $250,000 of professional liability insurance.


A) I only


B) I and II only


C) II and III only


D) All of the above. Answer: (b) I and II are true, [M.G.L Chapter 112:
Section 24B1/2(b) and 247 CMR 16.04(3)].


Collaborative drug therapy management may include:


a. collecting and reviewing patient histories;